Matches in Wikidata for { <http://www.wikidata.org/entity/Q91114852> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q91114852 description "article scientifique publié en 2018" @default.
- Q91114852 description "artículu científicu espublizáu n'agostu de 2018" @default.
- Q91114852 description "im August 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91114852 description "scientific article published on 01 August 2018" @default.
- Q91114852 description "wetenschappelijk artikel" @default.
- Q91114852 description "наукова стаття, опублікована в серпні 2018" @default.
- Q91114852 name "A Phase I/II Study of Crizotinib for Recurrent or Refractory Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma and a Phase I Study of Crizotinib for Recurrent or Refractory Neuroblastoma : Study Protocol for a Multicenter Single-arm" @default.
- Q91114852 name "A Phase I/II Study of Crizotinib for Recurrent or Refractory Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma and a Phase I Study of Crizotinib for Recurrent or Refractory Neuroblastoma : Study Protocol for a Multicenter Single-arm" @default.
- Q91114852 type Item @default.
- Q91114852 label "A Phase I/II Study of Crizotinib for Recurrent or Refractory Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma and a Phase I Study of Crizotinib for Recurrent or Refractory Neuroblastoma : Study Protocol for a Multicenter Single-arm" @default.
- Q91114852 label "A Phase I/II Study of Crizotinib for Recurrent or Refractory Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma and a Phase I Study of Crizotinib for Recurrent or Refractory Neuroblastoma : Study Protocol for a Multicenter Single-arm" @default.
- Q91114852 prefLabel "A Phase I/II Study of Crizotinib for Recurrent or Refractory Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma and a Phase I Study of Crizotinib for Recurrent or Refractory Neuroblastoma : Study Protocol for a Multicenter Single-arm" @default.
- Q91114852 prefLabel "A Phase I/II Study of Crizotinib for Recurrent or Refractory Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma and a Phase I Study of Crizotinib for Recurrent or Refractory Neuroblastoma : Study Protocol for a Multicenter Single-arm" @default.
- Q91114852 P1433 Q91114852-6C88EB4E-7B21-4FAD-970B-E91996E6E7DA @default.
- Q91114852 P1476 Q91114852-6730B7C9-B497-475B-BBEF-A1E48B8E23A9 @default.
- Q91114852 P2093 Q91114852-1EF8D068-3A70-4AC6-9981-9F9D6D47EC36 @default.
- Q91114852 P2093 Q91114852-427B9E6D-4615-4065-80FA-445D29160557 @default.
- Q91114852 P2093 Q91114852-A0C07FD0-7417-4F3B-9B6F-ECA2019E52AD @default.
- Q91114852 P2093 Q91114852-A137CB0D-0D88-4CCE-AF35-F3FABD835AC6 @default.
- Q91114852 P2093 Q91114852-CE45EB72-0A5C-4FB1-8A11-9BAADCF82B5C @default.
- Q91114852 P2093 Q91114852-E3CAD26C-ACDF-4596-90AD-7CC540E3B2E8 @default.
- Q91114852 P304 Q91114852-ACB56001-98AF-4615-9FAA-81F0011DD185 @default.
- Q91114852 P31 Q91114852-A63894CE-CD1E-4CC6-A272-AAB22EE5B07E @default.
- Q91114852 P356 Q91114852-BCFB0C66-A428-4E84-A211-4B2A68D197CC @default.
- Q91114852 P433 Q91114852-18ABEDE9-9685-429B-8F21-C78AA793DA70 @default.
- Q91114852 P478 Q91114852-2640805C-858A-44CE-9D0D-C3ADA8249B27 @default.
- Q91114852 P50 Q91114852-8D5383CD-B8C5-49F6-80BB-4A4B060B5D34 @default.
- Q91114852 P577 Q91114852-FAC8C9F7-5F30-4CCB-BE3D-06F253715234 @default.
- Q91114852 P698 Q91114852-C455ADB2-8E53-4575-919B-D58159822D5D @default.
- Q91114852 P921 Q91114852-30117FEE-EC9E-4D5A-988D-96669C4C172D @default.
- Q91114852 P921 Q91114852-52BC0C84-DE8C-4F0A-BA37-30BDB1279AF6 @default.
- Q91114852 P356 56184 @default.
- Q91114852 P698 30140094 @default.
- Q91114852 P1433 Q15756085 @default.
- Q91114852 P1476 "A Phase I/II Study of Crizotinib for Recurrent or Refractory Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma and a Phase I Study of Crizotinib for Recurrent or Refractory Neuroblastoma : Study Protocol for a Multicenter Single-arm Open-label Trial" @default.
- Q91114852 P2093 "Akiko Kada" @default.
- Q91114852 P2093 "Akiko M Saito" @default.
- Q91114852 P2093 "Masahiro Sekimizu" @default.
- Q91114852 P2093 "Reiji Fukano" @default.
- Q91114852 P2093 "Tetsuya Mori" @default.
- Q91114852 P2093 "Yuhki Koga" @default.
- Q91114852 P304 "431-436" @default.
- Q91114852 P31 Q13442814 @default.
- Q91114852 P356 "10.18926/AMO/56184" @default.
- Q91114852 P433 "4" @default.
- Q91114852 P478 "72" @default.
- Q91114852 P50 Q84782943 @default.
- Q91114852 P577 "2018-08-01T00:00:00Z" @default.
- Q91114852 P698 "30140094" @default.
- Q91114852 P921 Q111908491 @default.
- Q91114852 P921 Q938205 @default.